MIRA Pharmaceuticals MIRA Q3 2025 Earnings Why the Beat Matters LiqTech International LIQT Reports Mixed Q1 2026 Revenue Beats but EPS Misses Diamondrock DRH Q1 2026 Beat Revenue NA EPS Exceeds by Significant Fuse Group Holding Faces Persistent Challenges With Minimal Revenue and GoingConcern Uncertainty Orangekloud ORKT Q0 2024 Earnings Miss Sparks Concern UK Regulator Fines Suicide Forum 950000 Over UK User Access Failures Starmers EU Reset Ambitions Face Political Headwinds Market Implications